<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Merkely B</submitter><funding>British Heart Foundation</funding><funding>National Centre for the Replacement, Refinement and Reduction of Animals in Research</funding><funding>Medical Research Council</funding><pagination>869-78</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4367527</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(7)</volume><pubmed_abstract>Vascular derivatives of human embryonic stem cells (hESC) are being developed as sources of tissue-specific cells for organ regeneration. However, identity of developmental pathways that modulate the specification of endothelial cells is not known yet. We studied phosphatidylinositol 3-kinase (PI3K)-Forkhead box O transcription factor 1A (FOXO1A) pathways during differentiation of hESC toward endothelial lineage and on proliferation, maturation, and cell death of hESC-derived endothelial cells (hESC-EC). During differentiation of hESC, expression of FOXO1A transcription factor was linked to the expression of a cluster of angiogenesis- and vascular remodeling-related genes. PI3K inhibitor LY294002 activated FOXO1A and induced formation of CD31(+) hESC-EC. In contrast, differentiating hESC w</pubmed_abstract><journal>Stem cells and development</journal><pubmed_title>Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells.</pubmed_title><pmcid>PMC4367527</pmcid><funding_grant_id>RG/14/1/30588</funding_grant_id><funding_grant_id>MR/L012618/1</funding_grant_id><funding_grant_id>G1000035/1</funding_grant_id><pubmed_authors>Nemeth T</pubmed_authors><pubmed_authors>Mioulane M</pubmed_authors><pubmed_authors>Varady G</pubmed_authors><pubmed_authors>Merkely B</pubmed_authors><pubmed_authors>Zhou W</pubmed_authors><pubmed_authors>Harding SE</pubmed_authors><pubmed_authors>Lendvai Z</pubmed_authors><pubmed_authors>Skopal J</pubmed_authors><pubmed_authors>Kosztin A</pubmed_authors><pubmed_authors>Foldes G</pubmed_authors><pubmed_authors>Leja T</pubmed_authors><pubmed_authors>Bagyura Z</pubmed_authors><pubmed_authors>Gara E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells.</name><description>Vascular derivatives of human embryonic stem cells (hESC) are being developed as sources of tissue-specific cells for organ regeneration. However, identity of developmental pathways that modulate the specification of endothelial cells is not known yet. We studied phosphatidylinositol 3-kinase (PI3K)-Forkhead box O transcription factor 1A (FOXO1A) pathways during differentiation of hESC toward endothelial lineage and on proliferation, maturation, and cell death of hESC-derived endothelial cells (hESC-EC). During differentiation of hESC, expression of FOXO1A transcription factor was linked to the expression of a cluster of angiogenesis- and vascular remodeling-related genes. PI3K inhibitor LY294002 activated FOXO1A and induced formation of CD31(+) hESC-EC. In contrast, differentiating hESC w</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2026-05-03T06:59:49.815Z</modification><creation>2026-04-07T19:02:11.179Z</creation></dates><accession>S-EPMC4367527</accession><cross_references><pubmed>25387407</pubmed><doi>10.1089/scd.2014.0247</doi></cross_references></HashMap>